These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27002480)

  • 21. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
    Peng W; Zhang Y; Zhu R; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk.
    Aslebagh R; Whitham D; Channaveerappa D; Lowe J; Pentecost BT; Arcaro KF; Darie CC
    Electrophoresis; 2023 Jul; 44(13-14):1097-1113. PubMed ID: 36971330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
    Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
    J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
    Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers.
    Terkelsen T; Pernemalm M; Gromov P; Børresen-Dale AL; Krogh A; Haakensen VD; Lethiö J; Papaleo E; Gromova I
    Mol Oncol; 2021 Feb; 15(2):429-461. PubMed ID: 33176066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Proteomic Profiling of Extracellular Proteins between Normal and Gastric Cancer Cells.
    Kang M; Lu S; Chong PK; Yeoh KG; Lim YP
    Curr Cancer Drug Targets; 2016; 16(5):442-54. PubMed ID: 26648486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.
    Kang UB; Ahn Y; Lee JW; Kim YH; Kim J; Yu MH; Noh DY; Lee C
    BMC Cancer; 2010 Mar; 10():114. PubMed ID: 20346108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation.
    Xu D; Aka JA; Wang R; Lin SX
    J Steroid Biochem Mol Biol; 2017 Jul; 171():270-280. PubMed ID: 28457968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
    Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
    J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
    Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
    Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
    Jin L; Zhang Y; Li H; Yao L; Fu D; Yao X; Xu LX; Hu X; Hu G
    Cell Res; 2012 Sep; 22(9):1356-73. PubMed ID: 22688893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients.
    Ahmad N; Ammar A; Storr SJ; Green AR; Rakha E; Ellis IO; Martin SG
    Cancer Immunol Immunother; 2018 Apr; 67(4):537-549. PubMed ID: 29256156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
    Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
    Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.
    Kitakaze K; Tasaki C; Tajima Y; Hirokawa T; Tsuji D; Sakuraba H; Itoh K
    Biochem Biophys Rep; 2016 Sep; 7():157-163. PubMed ID: 28955902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural organization and expression of the gene for the mouse GM2 activator protein.
    Bertoni C; Appolloni MG; Stirling JL; Li SC; Li YT; Orlacchio A; Beccari T
    Mamm Genome; 1997 Feb; 8(2):90-3. PubMed ID: 9060405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
    Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
    Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.
    Hannafon BN; Gin AL; Xu YF; Bruns M; Calloway CL; Ding WQ
    Cell Commun Signal; 2019 Feb; 17(1):13. PubMed ID: 30782165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refined mapping of the GM2 activator protein (GM2A) locus to 5q31.3-q33.1, distal to the spinal muscular atrophy locus.
    Heng HH; Xie B; Shi XM; Tsui LC; Mahuran DJ
    Genomics; 1993 Nov; 18(2):429-31. PubMed ID: 8288250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.